ANDA Litigation Settlements

Spring 2015

GENERICally Speaking
Case Name Drug Patent No(s). Publicly Available Terms

Boehringer Ingelheim Pharma GMBH v. Amneal Pharms. LLC, 14-4726 (D.N.J.)

Aggrenox® (dipyridamole extended-release tablets)

6,015,577
6,673,372
6,939,964

Settlement releases all claims,
counterclaims, and affirmative defenses, and will remain in effect until the expiration of the patent-in-suit on Jan. 18, 2017.

Back to Top